|
|
 |
Designed for the perioperative care of surgical patients with a short period (6 to 12 hours) of intubation, the Sage CHG Surgical Continuum System combines our FDA-approved 2% Chlorhexidine Gluconate (CHG) Cloths for preoperative skin preparation with our proven comprehensive oral care system, now available with 0.12% Chlorhexidine Gluconate (CHG) Oral Rinse. |
Pharmacy-driven system
Because CHG Oral Rinse is a prescription drug, the oral care protocol is included on pre- and post-operative standing orders. This typically requires documentation on the Medication Administration Record (MAR) and provides an additional tool to track compliance. Product configuration and packaging allow for easy dispensing, and bedside or medication station storage. Tracking of compliance in all phases of the perioperative period is enhanced by MAR documentation and standing orders.
Boost compliance with Oral Check™
Oral Check is another way Sage is helping boost compliance to your protocol. Oral Check is a visual reminder for staff to scan the barcode on the back of the package and on the 0.12% CHG Oral Rinse bottle.
|
|
| |
Three-part system
The Sage CHG Surgical Continuum System allows the right tools to be distributed to the right unit for skin prep and oral care of the surgical patient.
The three-part system provides the correct tools packaged to be easily accessible to nurses as patients move through the perioperative period. Products are readily available as patients move from: 1. pre-surgery, 2. ICU and 3. step-down unit. Product components have been designed to match practice, while the configuration conforms to current hospital distribution from either the pharmacy or central supply, according to hospital protocol.
|
| |
The first and only FDA-approved preoperative skin prep in a cloth
Sage 2% CHG Cloths address multi-drug resistant organisms on the patient's skin. This is a known risk factor for SSIs.5 Sage's unique alcohol-free, rinse-free formula is designed for early preop prep. It is quick-drying and stays on skin for maximum persistence compared to other preop prep products. |
| |
Comprehensive oral care
Comprehensive oral hygiene addresses three VAP risk factors—bacterial colonization of the oropharyngeal area, aspiration of subglottic secretions and colonization of dental plaque with respiratory pathogens.17 Reducing bacterial colonization in the mouth and on the surface of teeth of ICU patients decreases the frequency of VAP.18 According to one study, "the most effective way to remove plaque is to use a brush."19 Toothette® Oral Care addresses VAP risk factors with a comprehensive approach based on cleaning, debriding, suctioning and moisturizing the entire oral cavity. All tools and interventions are designed to make it easier to maintain a healthy oral cavity. |
| |
First unit dose oral CHG rinse in a system
The CHG Surgical Continuum System includes 0.12% CHG Oral Rinse in a single-unit dose. The single-unit dose eliminates the need for a large, multi-use bottle. Staff is more efficient because there's no need for dispensing 0.12% CHG Oral Rinse into smaller containers. This minimizes waste, improves utilization and maximizes compliance to protocol.
CHG Oral Rinse:
Use with a toothbrush for plaque removal
Pleasant tasting
Tamper evident seal
|
| |
| 1. DeFrances CJ, Hall MJ, Podgornik MN, 2003 National hospital discharge survey. CDC, National Center for Health Statistics, Advance Data from Vital and Health Statistics. No. 359;8 July 2005:14. 2. Hall MJ, Lawrence L, Ambulatory surgery in the United States, 1996. CDC, National Center for Health Statistics, Advance Data from Vital and Health Statistics. No. 300;12 Aug1998:7. 3. Stone PW, et al., Am J Infect Control. Nov 2005;33(9):501-9. 4. Figure calculated by multiplying SSI rate from ref. #5 by surgical procedure numbers from ref. #1 and #2. 5. Mangram AJ, et al., Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention, Hospital Infection Control Practices Advisory Committee, Atlanta GA. 6. Kirkland KB, et al., Infect Control Hosp Epidemiol. Nov 1999;20(11):722-4. 7. Urban JA, Surg Infect. 2006 Jun;7 Suppl 1:S19-22. 8. Whitehouse JD, et al., Infect Control Hosp Epidemiol. 2002 Apr;23(4):183-9. 9. Schleder B, et al., J Advocate Health Care. 2002 Spr/Sum;4(1):27-30. 10. Tablan OC, et al., Guidelines for preventing health-care—associated pneumonia, 2003, Recommendations of CDC and Healthcare Infection Control Practices Advisory Committee (HICPAC), 2003. 11. Scannapieco FA, J Periodontology. 1999 Jul;70(7):793-802. 12. Scannapieco FA, et al., Crit Care Med. 1992 Jun;20(6):740-5. 13. Fourrier F, et al., Crit Care Med. 1998;26:301-8. 14. Munro CL, Grap MJ, Am J Crit Care. 2004 Jan;13(1):25-33. 15. Cason CL, et al., Am J Crit Care. 2007 Jan;16(1)28-38. 16. Rello J, et al., Chest. 2002 Dec;122(6):2115-21. 17. Kollef MH, et al., Chest. 2005;126(6):3854-62. 18. Vollman K, Garcia R, Miler L, AACN News. 2005 Aug;22(8):12-6. 19. Campbell DL, Ecklund MM. Development of a research-based oral care procedure for patients with artificial airways. NTI News (a publication of AACN's National Teaching Institute). 7 May 2002. |
| |
|
